David Harris Selected Research

Neoplasms (Cancer)

10/2023	Response Rates to Methylnaltrexone in Hospitalized Cancer Patients.
1/2023	An End-to-End Natural Language Processing System for Automatically Extracting Radiation Therapy Events From Clinical Texts.
1/2021	Heritable genetic variants in key cancer genes link cancer risk with anthropometric traits.
12/2020	Assessing the incidence of osteosarcoma among teriparatide users based on Medicare Part D and US State Cancer Registry Data.
1/2020	Impact of an Electronic Medical Record Alert on Code Status Documentation for Hospitalized Patients With Advanced Cancer.
1/2020	Exploratory examination of inflammation state, immune response and blood cell composition in a human obese cohort to identify potential markers predicting cancer risk.
2/2017	Ruxolitinib for symptom control in patients with chronic lymphocytic leukaemia: a single-group, phase 2 trial.
11/2016	Challenges in studying very rare cancer outcomes and infrequent exposures: example of teriparatide and osteosarcoma.
1/2016	An information model for computable cancer phenotypes.
6/2014	Interleukin-7 receptor-α gene mutations are not detected in adult T-cell acute lymphoblastic leukemia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Harris Research Topics

Disease

15	Neoplasms (Cancer) 10/2023 - 07/2006
14	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2009 - 01/2002
8	Leukemia 05/2009 - 07/2003
6	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2017 - 07/2010
6	Chronic Renal Insufficiency 01/2017 - 01/2004
4	Polycythemia Vera 08/2013 - 02/2008
4	Hematologic Neoplasms (Hematological Malignancy) 10/2011 - 01/2002
3	Osteosarcoma (Osteogenic Sarcoma) 01/2021 - 11/2016
3	Hearing Loss (Hearing Impairment) 01/2020 - 07/2014
3	Infections 01/2011 - 08/2002
2	COVID-19 10/2023 - 01/2021
2	Chronic Disease (Chronic Diseases) 06/2023 - 01/2020
2	Status Epilepticus (Complex Partial Status Epilepticus) 01/2023 - 01/2021
2	Inflammation (Inflammations) 10/2020 - 01/2009
2	Cognitive Dysfunction 01/2020 - 01/2019
2	Obesity 01/2020 - 01/2019
2	Chronic Kidney Failure (Chronic Renal Failure) 12/2016 - 10/2015
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/2014 - 03/2003
2	Feeding and Eating Disorders (Eating Disorder) 06/2012 - 12/2010
1	Cardiomyopathies (Cardiomyopathy) 01/2024
1	Pre-Eclampsia (Preeclampsia) 01/2024
1	Motor Skills Disorders (Motor Skills Disorder) 12/2023
1	Rheumatoid Arthritis 10/2023
1	Opioid-Induced Constipation 10/2023
1	Crystal Arthropathies 06/2023
1	Supraventricular Tachycardia 01/2023
1	Weight Loss (Weight Reduction) 01/2023
1	Ventricular Tachycardia 01/2023
1	Noncommunicable Diseases 11/2022
1	Obstructive Sleep Apnea 01/2022
1	Skin Neoplasms (Skin Cancer) 01/2021
1	Brain Neoplasms (Brain Tumor) 01/2021
1	Seizures (Absence Seizure) 01/2021
1	Osteoporosis 01/2021
1	Epilepsy (Aura) 01/2021
1	Disease Progression 10/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Coronary Disease (Coronary Heart Disease) 01/2019
1	Surgical Wound Infection 01/2018
1	Ileus 01/2018
1	Insulin Resistance 04/2017
1	Primary Myelofibrosis (Myelosclerosis) 02/2017
1	Melanoma (Melanoma, Malignant) 01/2017
1	Intractable Pain 01/2017
1	Proteinuria 01/2017

Drug/Important Bio-Agent (IBA)

8	CytokinesIBA 01/2020 - 07/2003
7	Proteins (Proteins, Gene)FDA Link 01/2024 - 04/2002
3	Teriparatide (Parathar)FDA Link 01/2021 - 11/2016
3	MicroRNAs (MicroRNA)IBA 01/2016 - 11/2008
3	azaspiraneIBA 10/2011 - 01/2007
3	Phosphotransferases (Kinase)IBA 10/2011 - 04/2006
3	Transcription Factors (Transcription Factor)IBA 01/2009 - 08/2003
2	3' Untranslated Regions (3' UTR)IBA 01/2021 - 11/2008
2	CreatinineIBA 01/2017 - 01/2004
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2014 - 07/2003
2	Messenger RNA (mRNA)IBA 12/2011 - 11/2008
2	RNA (Ribonucleic Acid)IBA 12/2011 - 04/2010
2	Cytarabine (Cytosar-U)FDA LinkGeneric 05/2009 - 12/2006
2	Caspase 3 (Caspase-3)IBA 05/2009 - 07/2003
2	NF-kappa B (NF-kB)IBA 01/2009 - 08/2003
2	EndotoxinsIBA 11/2008 - 08/2002
2	fms-Like Tyrosine Kinase 3IBA 02/2008 - 04/2006
2	WP1066IBA 02/2008 - 12/2007
1	ProlactinIBA 01/2024
1	dicarboxydine (DCD)IBA 12/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2023
1	mu Opioid Receptors (mu Opioid Receptor)IBA 10/2023
1	methylnaltrexone FDA Link 10/2023
1	Calcium PyrophosphateIBA 06/2023
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 06/2023
1	Ointments (Pastes)IBA 01/2023
1	P-2 (P 2)IBA 01/2021
1	Methohexital (Brevital)FDA Link 01/2021
1	DNA VaccinesIBA 10/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2017
1	Nonesterified Fatty Acids (NEFA)IBA 04/2017
1	ruxolitinibIBA 02/2017
1	dabrafenibIBA 01/2017

Therapy/Procedure

6	Therapeutics 11/2022 - 02/2008
2	Critical Care (Surgical Intensive Care) 01/2021 - 08/2002
2	Cochlear Implants (Cochlear Implant) 01/2019 - 07/2014
2	Renal Replacement Therapy (Therapies, Renal Replacement) 12/2016 - 10/2015
2	Drug Therapy (Chemotherapy) 12/2006 - 04/2006
1	Palliative Care (Palliative Therapy) 10/2023
1	Arthroplasty 06/2023
1	Electric Countershock (Cardioversion) 01/2023
1	Body Contouring 01/2023
1	Bariatric Surgery 01/2022
1	Continuous Positive Airway Pressure 01/2022
1	Injections 01/2021
1	Hearing Aids (Hearing Aid) 01/2020
1	Cardiopulmonary Resuscitation (CPR) 01/2020
1	Cochlear Implantation 01/2019
1	Blood Vessel Prosthesis 01/2019
1	Immunomodulation 01/2019
1	Operative Time 01/2018
1	Length of Stay 01/2018
1	Patient Readmission 01/2018